- Report
- May 2024
- 130 Pages
Global
From €3691EUR$3,999USD£3,090GBP
- Report
- February 2024
- 117 Pages
Global
From €4384EUR$4,750USD£3,670GBP
- Report
- August 2022
- 111 Pages
Global
From €4384EUR$4,750USD£3,670GBP
- Report
- January 2024
- 214 Pages
Global
€4610EUR$4,995USD£3,860GBP
- Report
- December 2023
- 182 Pages
Global
€4610EUR$4,995USD£3,860GBP
- Report
- August 2024
- 18 Pages
Global
From €13839EUR$14,995USD£11,587GBP
- Report
- August 2024
- 121 Pages
Global
From €13839EUR$14,995USD£11,587GBP
- Report
- February 2023
- 66 Pages
Global
From €3226EUR$3,495USD£2,701GBP
- Report
- January 2024
- 140 Pages
Global
From €3922EUR$4,250USD£3,284GBP
- Report
- March 2026
- 338 Pages
Canada
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2026
- 156 Pages
China
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2026
- 174 Pages
Germany
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2026
- 192 Pages
India
From €4476EUR$4,850USD£3,748GBP
- Report
- September 2025
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- June 2025
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2025
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2025
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- August 2026
- 160 Pages
Nigeria
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- April 2024
- 128 Pages
North America
From €1384EUR$1,500USD£1,159GBP
- Report
- September 2023
- 274 Pages
Global
From €3322EUR$3,600USD£2,782GBP

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics.
The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more